WheatLJFreifeldAGKleimanMB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807-825. doi:10.1086/521259
4.
OuelletteCPStanekJRLeberAArduraMI.Pediatric histoplasmosis in an area of endemicity: a contemporary analysis. J Pediatric Infect Dis Soc. 2019;8:400-407. doi:10.1093/JPIDS/PIY073
5.
StrockSBGaudieriSMallalS, et al. Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02—a case control study. BMC Infect Dis. 2015;15:206. doi:10.1186/s12879-015-0943-7
6.
AzarMMHageCA.Laboratory diagnostics for histoplasmosis. J Clin Microbiol. 2017;55:1612-1620. doi:10.1128/JCM.02430-16
7.
WheatJFrenchMLVKohlerRB, et al. The diagnostic laboratory tests for histoplasmosis. Analysis of experience in a large urban outbreak. Ann Intern Med. 1982;97:680-685. doi:10.7326/0003-4819-97-5-680
8.
GuarnerJBrandtME.Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev. 2011;24:247-280. doi:10.1128/CMR.00053-10
9.
NaeemFMetzgerMLArnoldSRAddersonEE.Distin-guishing benign mediastinal masses from malignancy in a histoplasmosis-endemic region. J Pediatr. 2015;167:409-415. doi:10.1016/j.jpeds.2015.04.066
10.
OzolsIIWheatLJ. Erythema nodosum in an epidemic of histoplasmosis in Indianapolis. Arch Dermatol. 1981;117:709-712. doi:10.1001/archderm.1981.01650110031014
11.
ChowaniecMStarbaAWilandP.Erythema nodosum—review of the literature. Reumatologia. 2016;54:79-82. doi:10.5114/reum.2016.60217